Inventiva S.A. Form 6-K Summary
Business context and reporting period
Inventiva S.A., a French biotechnology company, filed this Form 6-K for April 2022. The filing reports shareholder meeting materials distributed to beneficial owners of the company’s American Depositary Shares.
Material filing event
On April 25, 2022, the company began mailing its proxy card and voting instructions for its Ordinary and Extraordinary General Meeting, scheduled for May 19, 2022, at 2:00 p.m. at Hôtel Oceania Le Jura in Dijon, France.
Financial metrics and liquidity
This filing does not provide revenue, profit, cash flow, margins, debt, liquidity, or other financial metrics.
Guidance, outlook, risks, and unusual items
The filing does not provide financial guidance, operating outlook, risk updates, contingencies, or unusual financial items. Its purpose is to furnish shareholder voting materials.
Exhibits
- Exhibit 99.1: Proxy Card.
- Exhibit 99.2: Instructions for Beneficial Owners of American Depositary Shares.
Key facts to verify
- Review the proxy card for the specific resolutions submitted to shareholders.
- Review the voting instructions for eligibility, voting procedures, deadlines, and broker-related requirements.
- Confirm the outcome of the May 19, 2022 Ordinary and Extraordinary General Meeting in subsequent company disclosures.